American Bio Medica Corp (ABMC) SEC Filing 10-Q Quarterly report for the period ending Saturday, March 31, 2018

American Bio Medica Corp

CIK: 896747 Ticker: ABMC
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2018
May 14, 2018
Document And Entity Information [Abstract]  
Document Type10-Q 
Amendment Flagfalse 
Document Period End DateMar. 31, 2018 
Document Fiscal Year Focus2018 
Document Fiscal Period FocusQ1 
Entity Central Index Key0000896747 
Current Fiscal Year End Date--12-31 
Entity Filer CategorySmaller Reporting Company 
Trading SymbolABMC 
Entity Common Stock, Shares Outstanding 29,932,770

View differences made from one quarter to another to evaluate American Bio Medica Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Bio Medica Corp.


Assess how American Bio Medica Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

American Bio Medica Corp provided additional information to their SEC Filing as exhibits

Ticker: ABMC
CIK: 896747
Form Type: 10-Q Quarterly Report
Accession Number: 0001654954-18-005248
Submitted to the SEC: Mon May 14 2018 5:21:17 PM EST
Accepted by the SEC: Mon May 14 2018
Period: Saturday, March 31, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: